Jiangyin Berison Biochemical Technology

Jiangyin Berison Biochemical Technology is a Chinese biotechnology company specializing in the development of marine-derived biological materials for medical applications. The company focuses on the extraction and application of cold-adapted enzymes, particularly trypsin derived from Antarctic krill, to treat wounds, inflammation, and skin conditions. Their product portfolio includes advanced medical dressings, scar repair gels, and treatments for dermatitis, many of which are marketed under the Berison brand. Founded by experts in biochemical engineering, the firm bridges the gap between marine biology and clinical medicine through its proprietary enzyme stabilization technology. Berison operates manufacturing facilities that comply with medical device standards and actively collaborates with clinical institutions to expand its therapeutic reach. The company's research into marine enzymes has positioned it as a leader in the high-value utilization of Antarctic krill resources for the healthcare sector.